Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):961–964. doi: 10.1128/aac.41.5.961

Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats.

Z Song 1, H K Johansen 1, V Faber 1, C Moser 1, A Kharazmi 1, J Rygaard 1, N Høiby 1
PMCID: PMC163833  PMID: 9145852

Abstract

The predominant pathogen in patients with cystic fibrosis (CF) is Pseudomonas aeruginosa, which results in a chronic lung infection associated with progressive pulmonary insufficiency. In a rat model of chronic P. aeruginosa pneumonia mimicking that in patients with CF, we studied whether the inflammation and antibody responses could be changed by treatment with the Chinese herbal medicine ginseng. An aqueous extract of ginseng was injected subcutaneously, and cortisone and saline were used as controls. Two weeks after challenge with P. aeruginosa, the ginseng-treated group showed a significantly improved bacterial clearance from the lungs (P < 0.04), less severe lung pathology (P = 0.05), lower lung abscess incidence (P < 0.01), and fewer mast cell numbers in the lung foci (P < 0.005). Furthermore, lower total immunoglobulin G (IgG) levels (P < 0.01) and higher IgG2a levels (P < 0.025) in serum against P. aeruginosa sonicate and a shift from an acute type to a chronic type of lung inflammation compared to those in the control and cortisone-treated groups were observed. These findings indicate that ginseng treatment of an experimental P. aeruginosa pneumonia in rats promotes a cellular response resembling a TH1-like response. On the basis of these results it is suggested that ginseng may have the potential to be a promising natural medicine, in conjunction with other forms of treatment, for CF patients with chronic P. aeruginosa lung infection.

Full Text

The Full Text of this article is available as a PDF (233.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baek L. New, sensitive rocket immunoelectrophoretic assay for measurement of the reaction between endotoxin and Limulus amoebocyte lysate. J Clin Microbiol. 1983 Jun;17(6):1013–1020. doi: 10.1128/jcm.17.6.1013-1020.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS. 1995 Mar;103(3):161–179. doi: 10.1111/j.1699-0463.1995.tb01092.x. [DOI] [PubMed] [Google Scholar]
  3. De Franco M., Gille-Perramant M. F., Mevel J. C., Couderc J. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis. Eur J Immunol. 1995 Jan;25(1):132–136. doi: 10.1002/eji.1830250123. [DOI] [PubMed] [Google Scholar]
  4. Eigen H., Rosenstein B. J., FitzSimmons S., Schidlow D. V. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr. 1995 Apr;126(4):515–523. doi: 10.1016/s0022-3476(95)70343-8. [DOI] [PubMed] [Google Scholar]
  5. Ho A. S., Moore K. W. Interleukin-10 and its receptor. Ther Immunol. 1994 Jun;1(3):173–185. [PubMed] [Google Scholar]
  6. Hu S., Concha C., Cooray R., Holmberg O. Ginseng-enhanced oxidative and phagocytic activities of polymorphonuclear leucocytes from bovine peripheral blood and stripping milk. Vet Res. 1995;26(3):155–161. [PubMed] [Google Scholar]
  7. Høiby N. Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax. 1994 Jun;49(6):531–532. doi: 10.1136/thx.49.6.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jackson R. J., Staats H. F., Xu-Amano J., Takahashi I., Kiyono H., Hudson M. E., Gilley R. M., Chatfield S. N., McGhee J. R. Oral vaccine models: multiple delivery systems employing tetanus toxoid. Ann N Y Acad Sci. 1994 Aug 15;730:217–234. doi: 10.1111/j.1749-6632.1994.tb44251.x. [DOI] [PubMed] [Google Scholar]
  9. Johansen H. K., Espersen F., Cryz S. J., Jr, Hougen H. P., Fomsgaard A., Rygaard J., Høiby N. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect Immun. 1994 Aug;62(8):3146–3155. doi: 10.1128/iai.62.8.3146-3155.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johansen H. K., Espersen F., Pedersen S. S., Hougen H. P., Rygaard J., Høiby N. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS. 1993 Mar;101(3):207–225. [PubMed] [Google Scholar]
  11. Johansen H. K., Hougen H. P., Cryz S. J., Jr, Rygaard J., Høiby N. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1337–1346. doi: 10.1164/ajrccm.152.4.7551392. [DOI] [PubMed] [Google Scholar]
  12. Johansen H. K., Hougen H. P., Rygaard J., Høiby N. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol. 1996 Feb;103(2):212–218. doi: 10.1046/j.1365-2249.1996.d01-618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Johansen H. K., Høiby N., Pedersen S. S. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses. APMIS. 1991 Dec;99(12):1061–1068. [PubMed] [Google Scholar]
  14. Kemp M., Theander T. G., Kharazmi A. The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today. 1996 Jan;17(1):13–16. doi: 10.1016/0167-5699(96)80562-7. [DOI] [PubMed] [Google Scholar]
  15. Lange K. H., Hougen H. P., Høiby N., Fomsgaard A., Rygaard J., Johansen H. K. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. APMIS. 1995 May;103(5):367–374. [PubMed] [Google Scholar]
  16. Lawrence R. A., Allen J. E., Gregory W. F., Kopf M., Maizels R. M. Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response. J Immunol. 1995 Jun 1;154(11):5995–6001. [PubMed] [Google Scholar]
  17. Lemire J. M., Archer D. C., Beck L., Spiegelberg H. L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995 Jun;125(6 Suppl):1704S–1708S. doi: 10.1093/jn/125.suppl_6.1704S. [DOI] [PubMed] [Google Scholar]
  18. Liu C. X., Xiao P. G. Recent advances on ginseng research in China. J Ethnopharmacol. 1992 Feb;36(1):27–38. doi: 10.1016/0378-8741(92)90057-x. [DOI] [PubMed] [Google Scholar]
  19. Miller K. J., Wood J. M. Osmoadaptation by rhizosphere bacteria. Annu Rev Microbiol. 1996;50:101–136. doi: 10.1146/annurev.micro.50.1.101. [DOI] [PubMed] [Google Scholar]
  20. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996 Mar;17(3):138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  21. Nikolaizik W. H., Schöni M. H. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. J Pediatr. 1996 Feb;128(2):271–274. doi: 10.1016/s0022-3476(96)70407-9. [DOI] [PubMed] [Google Scholar]
  22. Pedersen S. S. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl. 1992;28:1–79. [PubMed] [Google Scholar]
  23. Pedersen S. S., Shand G. H., Hansen B. L., Hansen G. N. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. APMIS. 1990 Mar;98(3):203–211. [PubMed] [Google Scholar]
  24. Song Z., Johansen H. K., Moser C., Høiby N. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection. APMIS. 1996 May;104(5):350–354. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES